Effect of fixed-ratio insulin combinations on adherence in type 2 diabetes: Systematic review

被引:1
作者
Elamin, Mohamed [1 ]
Barnish, Maxwell S. [2 ]
机构
[1] Univ Exeter, Med Sch, Exeter, England
[2] Univ Exeter, Med Sch, Dept Publ Hlth & Sports Sci, Exeter, England
关键词
Type; 2; diabetes; Fixed -ratio combinations; Adherence; Narrative synthesis; BASAL INSULIN; REAL-WORLD; IDEGLIRA; BARRIERS; THERAPY; PEOPLE; SAFETY;
D O I
10.1016/j.dsx.2024.103072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To systematically review evidence on the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Methods: Systematic searches were conducted using MEDLINE and EMBASE in March 2023. Standardised screening, data extraction and risk of bias assessment were conducted. All review procedures were conducted independently by two reviewers. Eligible studies assessed the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Narrative synthesis was conducted to analyse findings. Results: A total of 488 records were identified, of which 37 proceeded to full-text screening and 7 - each representing a unique study - were included in the systematic review. Among the included studies, 3 were randomised controlled trials and 4 were cohort studies. Following narrative synthesis, it was shown that fixed-ratio combinations improved patient satisfaction and treatment adherence. Conclusions: Available evidence supports a benefit for fixed-ratio combinations on patient satisfaction and treatment adherence in people with type 2 diabetes.
引用
收藏
页数:7
相关论文
共 37 条
[1]   Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration [J].
Abu Hassan, Hasliza ;
Tohid, Hizlinda ;
Amin, Rahmah Mohd ;
Bidin, Mohamed Badrulnizam Long ;
Muthupalaniappen, Leelavathi ;
Omar, Khairani .
BMC FAMILY PRACTICE, 2013, 14
[3]  
[Anonymous], 2022, Type 2 diabetes in adults: management
[4]   Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs [J].
Baser, Onur ;
Tangirala, Krishna ;
Wei, Wenhui ;
Xie, Lin .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 :497-505
[5]   Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial [J].
Billings, Liana K. ;
Doshi, Ankur ;
Gouet, Didier ;
Oviedo, Alejandra ;
Rodbard, Helena W. ;
Tentolouris, Nikolaos ;
Gron, Randi ;
Halladin, Natalie ;
Jodar, Esteban .
DIABETES CARE, 2018, 41 (05) :1009-1016
[6]   Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial [J].
Blonde, Lawrence ;
Rosenstock, Julio ;
Del Prato, Stefano ;
Henry, Robert ;
Shehadeh, Naim ;
Frias, Juan ;
Niemoeller, Elisabeth ;
Souhami, Elisabeth ;
Li, Chen ;
Aroda, Vanita R. .
DIABETES CARE, 2019, 42 (11) :2108-2116
[7]   Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses [J].
Brod, Meryl ;
Rana, Azhar ;
Barnett, Anthony H. .
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (12) :1933-1946
[8]  
Brod Meryl, 2012, J Med Econ, V15, P77, DOI 10.3111/13696998.2011.624144
[9]  
casp-uk, CASP COHORT STUDY CH
[10]  
Cochrane Library, Rob 2: A Revised Cochrane Risk-of- -Bias Tool for Randomized Trials | Cochrane Bias